TRex Bio, Inc. (TRXB)
NASDAQ: TRXB · Real-Time Price · USD
15.49
+0.25 (1.64%)
At close: Oct 22, 2026, 4:00 PM EDT
15.50
+0.01 (0.06%)
After-hours: Oct 22, 2026, 7:30 PM EDT

TRex Bio Statistics

Total Valuation

TRex Bio has a market cap or net worth of $417.29 million. The enterprise value is $326.63 million.

Market Cap417.29M
Enterprise Value 326.63M

Important Dates

The next estimated earnings date is Thursday, November 12, 2026, after market close.

Earnings Date Nov 12, 2026
Ex-Dividend Date n/a

Share Statistics

TRex Bio has 26.92 million shares outstanding.

Current Share Class 26.92M
Shares Outstanding 26.92M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 1.92%
Owned by Institutions (%) 17.42%
Float 13.43M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 4.76
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 12.18, with a Debt / Equity ratio of 0.00.

Current Ratio 12.18
Quick Ratio 11.87
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -55.80%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee -$773,200
Employee Count60
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, TRex Bio has paid $88,000 in taxes.

Income Tax 88,000
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) n/a
Average Volume (20 Days) 247,834

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -49.64M
Pretax Income -46.30M
Net Income -46.39M
EBITDA -49.41M
EBIT -49.64M
Earnings Per Share (EPS) -$10.48
Full Income Statement

Balance Sheet

The company has $90.85 million in cash and $197,000 in debt, with a net cash position of $90.66 million or $3.37 per share.

Cash & Cash Equivalents 90.85M
Total Debt 197,000
Net Cash 90.66M
Net Cash Per Share $3.37
Equity (Book Value) 87.63M
Book Value Per Share -25.40
Working Capital 85.60M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$46.25 million and capital expenditures -$57,000, giving a free cash flow of -$46.31 million.

Operating Cash Flow -46.25M
Capital Expenditures -57,000
Depreciation & Amortization 225,000
Net Borrowing n/a
Free Cash Flow -46.31M
FCF Per Share -$1.72
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

TRex Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -67.61%
FCF Yield -11.10%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1